Under the Human Medicines Regulations 2012, selling or supplying either compound with therapeutic claims in the UK without a Marketing Authorisation is illegal
First characterised in research at the University of Texas Health Science Center, 5-Amino-1MQ represents a fundamentally different approach to metabolic research one that targets the energy machinery inside fat cells directly, rather than working through hormonal or appetite-based pathways
Ingredients: Lipotropic (MIC: Methionine, Inositol, Choline) B12 (100mcg/mL methylcobalamin) REQUIREMENT: Upon approval of the physician, medications are shipped out
Research-Based Cycle Protocols Short-Term Assessment (4-8 Weeks): An initial 4-8 week cycle allows evaluation of individual response, tolerance assessment, and metabolic changes without extended commitment
Monthly injections are well suited to maintenance, keeping already-healthy levels healthy, but they are often not enough during the correction phase for someone who is significantly deficient